BWA
ONC

Basecamp Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Basecamp Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43K Sell
151
-114
-43% -$33.6K 0.01% 580
2026
Q1 		$78.7K Buy
265
+4
+2% +$1.29K 0.02% 446
2025
Q4 		$79.3K Buy
+261
New +$85.4K 0.02% 426

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Basecamp Wealth Advisors's ONC Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its BeOne Medicines Ltd (ONC) stake by 43% in Q2 2026, selling an estimated $33.6K and leaving 151 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #580.

Basecamp Wealth Advisors first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $79.3K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Basecamp Wealth Advisors held 151 shares of BeOne Medicines Ltd worth $43K as of Q2 2026.
  • Basecamp Wealth Advisors sold 114 BeOne Medicines Ltd shares in Q2 2026, an estimated $33.6K.
  • BeOne Medicines Ltd made up 0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #580 holding.
  • Basecamp Wealth Advisors first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's BeOne Medicines Ltd position peaked at $79.3K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.